BioAdaptives, Inc. Announces National Launch of NeuroRush(TM) Nootropic in 2025
July 16th, 2025 1:35 PM
By: Newsworthy Staff
BioAdaptives, Inc. is set to launch NeuroRush(TM), a nootropic designed to enhance cognitive functions, in late summer 2025, following successful test market results.
BioAdaptives, Inc. (OTC Pink: BDPT) has announced the national launch of NeuroRush(TM), its innovative nootropic aimed at improving mental clarity, cognitive endurance, and stress adaptability, scheduled for late summer 2025. The product, which comes in two versions—one with natural caffeine and one caffeine-free—has shown promising results in test markets. NeuroRush(TM) is formulated with clinically studied ingredients such as Rhodiola, Ashwagandha, and Bacopa, offering support for brain health without the adverse effects commonly associated with stimulants. The nootropic will be available for purchase online and through select wellness partners, marking a significant step in BioAdaptives' commitment to enhancing cognitive wellness through natural solutions.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
